Neurocrine Biosciences and Voyager Therapeutics has announced the formation of a strategic collaboration focused on the ...
Pfizer and Eli Lilly have announced positive top-line results from a Phase 3 study evaluating tanezumab 2.5 mg or 5 mg i...
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) ...
Commercial stage biopharma company, Basilea Pharmaceutica has announced that it entered into a collaboration with Roche ...
UK based biopharma company, Wren Therapeutics focused on drug discovery and development for protein misfolding diseases ...
AbbVie, a research-based global biopharmaceutical company has announced an update on the Phase 3 RESOLVE trial (PCYC-113...
Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a Group Type II Variation ...
Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurode...
Amgen and UCB announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorizat...
Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Minist...
Cellular Biomedicine Group Inc., a biopharmaceutical firm engaged in the development of immunotherapies for cancer and s...
Oculis SA, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments recently ...
Biopharma company, AbbVie and Biotech company, Tizona Therapeutics has announced that they have entered into a global, s...
Bristol-Myers Squibb Company has announced the U.S. Food and Drug Administration (FDA) has expanded the indication for&n...
AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy e...
Pharma major Lupin announced that it has received approval for its Clobazam Oral Suspension, 2.5 mg/mL from the United S...
Teva Pharmaceutical Industries Ltd., today announced the launch of a generic version of Elidel®1 (pimecrolimus)...
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecul...
Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfa...
Cannabics Pharmaceuticals Inc., a world leader in personalized cannabinoid medicine focused on cancer and its side effec...
I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the developm...
Roivant Sciences has announced that it has entered into collaboration with Daiichi Sankyo Company, Limited (hereafter, D...
Biopharma company Lexicon Pharmaceuticals, Inc. has announced positive topline results from its Phase 1a study of LX9211...
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, has signed a licen...
